Document is current

Article History

First Online: 14 August 2020

Declarations

:

: KvH reports having received a research grant from Mundipharma Comm. VA and Celltrion Healthcare Co. SV is a senior clinical investigator of the Research Foundation—Flanders (FWO).

: KvH reports having received a speaker’s fee from Takeda. SV reports having received research grants from MSD, AbbVie, Takeda, Janssen, and Pfizer; consultancy fees from AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead, and Janssen; and speakers fees from AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable code.

: All authors contributed to the study conception and design. Literature research was performed by KvH. The first draft of the manuscript was written by KvH and was critically revised by SV. All authors read and approved the final manuscript.

Free to read: This content has been made available to all.